Drugs / mononuclear cells from umbilical cord blood
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07208344 | Jul → Dec 2025 overdue | Alzheimer disease | Anhui Provincial Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mononuclear cells from umbilical cord blood | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07208344 ↗ |
| Known as | UCB-MNCs | “The low-dose group receives 1×10⁸ UCB-derived mononuclear cells (UCB-MNCs) per infusion” NCT07208344 ↗ |
| Route | Intravenous | “The infusions will be carried out via the intravenous route” NCT07208344 ↗ |